Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
AMPE.US
id: 111, Created by Stan Vick, Scout

Ampio Pharm

D. Colorado
Court
The Company issued a letter to Shareholders covering the initial results of the investigation initiated on May 16, 2022.
Special Committee's primary findings include that certain former Ampio executive officers and senior staff were aware, at the time of the per-protocol interim analysis in March 2020, that the AP-013 trial did not demonstrate efficacy for Ampion on its co-primary endpoints of pain and function; and that these former Ampio executive officers and senior staff did not fully report the results of the AP-013 trial and the timing of unblinding of data from the AP-013 trial.

Alleged Offence
Fraud
Failure to Disclose
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
03 August 2022
Collecting participants…
Created by Stan Vick, Scout

Ampio Pharm

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprieta...

    Ticker
    AMPE.US
    ISIN
    US03209T1097
    CIK
    1411906
    Sector
    Healthcare
    Industry
    Biotechnology
    Country
    USA
    Address
    373 Inverness Parkway, Englewood, CO, United States, 80112